Direct and Indirect Protein Interactions Link FUS Aggregation to Histone Post-Translational Modification Dysregulation and Growth Suppression in an ALS/FTD Yeast Model
Authors:
- Seth A. BennettSBSeth A. Bennett
- Samantha N. CobosSCSamantha N. Cobos
- Raven M. A. FisherRFRaven M. A. Fisher
- Elizaveta SonESElizaveta Son
- Rania FredericRFRania Frederic
- Rianna SegalRSRianna Segal
- Huda YousufHYHuda Yousuf
- Kaitlyn ChanKCKaitlyn Chan
- David K. DansuDDDavid K. Dansu
- Mariana P. TorrenteMTMariana P. Torrente
Open Access
- 14 January 2025
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (1) , 58
Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are incurable neurodegenerative disorders sharing pathological and genetic features, including mutations in the FUS gene. FUS is an RNA-binding protein that mislocalizes to the cytoplasm and aggregates in ALS/FTD. In a yeast model, FUS proteinopathy is connected to changes in the epigenome, including reductions in the levels of H3S10ph, H3K14ac, and H3K56ac. Exploiting the same model, we reveal novel connections between FUS aggregation and epigenetic dysregulation. We show that the histone-modifying enzymes Ipl1 and Rtt109—responsible for installing H3S10ph and H3K56ac—are excluded from the nucleus in the context of FUS proteinopathy. Furthermore, we found that Ipl1 colocalizes with FUS, but does not bind it directly. We identified Nop1 and Rrp5, a histone methyltransferase and rRNA biogenesis protein, respectively, as FUS binding partners involved in the growth suppression phenotype connected to FUS proteinopathy. We propose that the nuclear exclusion of Ipl1 through indirect interaction with FUS drives the dysregulation of H3S10ph as well as H3K14ac via crosstalk. We found that the knockdown of Nop1 interferes with these processes. In a parallel mechanism, Rtt109 mislocalization results in reduced levels of H3K56ac. Our results highlight the contribution of epigenetic mechanisms to ALS/FTD and identify novel targets for possible therapeutic intervention.Keywords
Funding Information
- Brooklyn College (K22NS09131401, R15NS125394, R15NS125394-01S1, K12GM102778, 1S10OD010582-01A1, R35-NS111604)
- CUNY (K22NS09131401, R15NS125394, R15NS125394-01S1, K12GM102778, 1S10OD010582-01A1, R35-NS111604)
- NIH (K22NS09131401, R15NS125394, R15NS125394-01S1, K12GM102778, 1S10OD010582-01A1, R35-NS111604)
- Graduate Center, CUNY (K22NS09131401, R15NS125394, R15NS125394-01S1, K12GM102778, 1S10OD010582-01A1, R35-NS111604)
- National Institute Neurological Disorders and Stroke of Health (K22NS09131401, R15NS125394, R15NS125394-01S1, K12GM102778, 1S10OD010582-01A1, R35-NS111604)
This publication has 106 references indexed in Scilit:
- Damaging de novo missense variants inEEF1A2lead to a developmental and degenerative epileptic‐dyskinetic encephalopathyHuman Mutation, 2020
- Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS modelsCell Stress and Chaperones, 2020
- Toward understanding the origin and evolution of cellular organismsProtein Science, 2019
- The DDX5/Dbp2 subfamily of DEAD‐box RNA helicasesWIREs RNA, 2018
- Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2009
- Targeting histone deacetylases for the treatment of cancer and inflammatory diseasesJournal of Cellular Physiology, 2006
- Identification of a novel protein from glial cells based on its ability to interact with NF‐κB subunitsrJournal of Cellular Biochemistry, 2003
- RRP5 is required for formation of both 18S and 5.8S rRNA in yeast.The EMBO Journal, 1996
- Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1Cell, 1991
- A yeast nucleolar protein related to mammalian fibrillarin is associated with small nucleolar RNA and is essential for viability.The EMBO Journal, 1989